Literature DB >> 786888

Phage conversion to hemagglutinin production in Clostridium botulinum types C and D.

K Oguma, H Iida, M Shiozaki.   

Abstract

Five toxigenic strains of Clostridium botulinum types C and D were incubated at 37 degrees C for 7 days in 15 ml of the following media: LYG medium, cooked-meat medium, egg meat medium, and N-Z-amine medium. The supernatants of these cultures were tested for hemagglutinin production with 1% erythrocytes obtained from mice, guinea pigs, chickens, sheep, monkeys, and humans. Four toxigenic strains produced hemagglutinin. The highest hemagglutinin titer was obtained with a combination of human erythrocytes and cultures incubated in LYG medium. When the same experiment was carried out with many nontoxigenic strains, hemagglutination was observed in only one strain, C-N71. Strains producing hemagglutinin also produced phages. The phages obtained from toxin- and hemagglutinin-producing strains converted nontoxigenic indicator strains to produce both toxin and hemagglutinin. The phage obtained from a toxin-positive hemagglutinin-negative strain could only induce cultures to produce toxin, and the phage from a toxin-negative hemagglutinin-positive strain could only induce production of hemagglutinin. These studies suggest that the production of hemagglutinin by C. botulinum types C and D is governed by bacteriophages and that hemagglutinin production can be transmitted separately or concomitantly with toxin production.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 786888      PMCID: PMC420926          DOI: 10.1128/iai.14.3.597-602.1976

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  Hemagglutination by Clostridium botulinum type D.

Authors:  M STERNE
Journal:  Science       Date:  1954-04-02       Impact factor: 47.728

2.  Characterization of botulinal hemagglutination.

Authors:  J P LOWENTHAL; C LAMANNA
Journal:  Am J Hyg       Date:  1953-01

3.  Activation of a toxic component of Clostridium botulinum types C and D by trypsin.

Authors:  M W Eklund; F T Poysky
Journal:  Appl Microbiol       Date:  1972-07

4.  Electron microscopy of the toxin and hemagglutinin of type A Clostridium botulinum.

Authors:  D A Boroff; S Nyberg; S Höglund
Journal:  Infect Immun       Date:  1972-12       Impact factor: 3.441

5.  Observations on receptor specific proteins. II. Haemagglutination and haemagglutination-inhibition reactions of Clostridium botulinum types A, C, D and E haemagglutinins.

Authors:  P Balding; E R Gold; D A Boroff; T A Roberts
Journal:  Immunology       Date:  1973-11       Impact factor: 7.397

6.  Bacteriophage and toxigenicity in Clostridium botulinum: an additional evidence for phage conversion.

Authors:  K Oguma; H Iida; K Inoue
Journal:  Jpn J Microbiol       Date:  1973-09

7.  Bacteriophage and the toxigenicity of Clostridium botulinum type D.

Authors:  M W Eklund; F T Poysky; S M Reed
Journal:  Nat New Biol       Date:  1972-01-05

8.  Conversion of toxigenicity in Clostridium botulinum type C.

Authors:  K Inoue; H Iida
Journal:  Jpn J Microbiol       Date:  1970-01

9.  Purification and crystallization of Clostridium botulinum type C toxin.

Authors:  B Syuto; S Kubo
Journal:  Jpn J Vet Res       Date:  1972-06       Impact factor: 0.649

10.  Interconversion of type C and D strains of Clostridium botulinum by specific bacteriophages.

Authors:  M W Eklund; F T Poysky
Journal:  Appl Microbiol       Date:  1974-01
View more
  14 in total

1.  Cloning and complete nucleotide sequence of the gene for the main component of hemagglutinin produced by Clostridium botulinum type C.

Authors:  K Tsuzuki; K Kimura; N Fujii; N Yokosawa; T Indoh; T Murakami; K Oguma
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

2.  Clostridium botulinum types A, B, C1, and E produce proteins with or without hemagglutinating activity: do they share common amino acid sequences and genes?

Authors:  E Somers; B R DasGupta
Journal:  J Protein Chem       Date:  1991-08

3.  Molecular analysis of an extrachromosomal element containing the C2 toxin gene discovered in Clostridium botulinum type C.

Authors:  Yoshihiko Sakaguchi; Tetsuya Hayashi; Yumiko Yamamoto; Keisuke Nakayama; Kai Zhang; Shaobo Ma; Hideyuki Arimitsu; Keiji Oguma
Journal:  J Bacteriol       Date:  2009-03-06       Impact factor: 3.490

Review 4.  Properties and use of botulinum toxin and other microbial neurotoxins in medicine.

Authors:  E J Schantz; E A Johnson
Journal:  Microbiol Rev       Date:  1992-03

5.  Observations on toxin and hemagglutinin produced by Clostridium botulinum type C.

Authors:  K Oguma; A Nakane; H Iida
Journal:  Appl Environ Microbiol       Date:  1978-02       Impact factor: 4.792

6.  Construction of "Toxin Complex" in a Mutant Serotype C Strain of Clostridium botulinum Harboring a Defective Neurotoxin Gene.

Authors:  Tomonori Suzuki; Thomas Nagano; Koichi Niwa; Masataka Uchino; Motohiro Tomizawa; Yoshimasa Sagane; Toshihiro Watanabe
Journal:  Curr Microbiol       Date:  2016-10-26       Impact factor: 2.188

7.  Two different types of ADP-ribosyltransferase C3 from Clostridium botulinum type D lysogenized organisms.

Authors:  K Moriishi; B Syuto; M Saito; K Oguma; N Fujii; N Abe; M Naiki
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

Review 8.  Clostridium botulinum neurotoxin.

Authors:  H Sugiyama
Journal:  Microbiol Rev       Date:  1980-09

9.  Antigenic similarity of toxins produced by Clostridium botulinum type C and D strains.

Authors:  K Oguma; B Syuto; H Iida; S Kubo
Journal:  Infect Immun       Date:  1980-12       Impact factor: 3.441

10.  Characterization of bacteriophage nucleic acids obtained from Clostridium botulinum types C and D.

Authors:  N Fujii; K Oguma; N Yokosawa; K Kimura; K Tsuzuki
Journal:  Appl Environ Microbiol       Date:  1988-01       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.